Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience

Conclusion: We observed serum ferritin, D-dimer and CRP to accurately predict patients developing severe COVID-19 infections as well as those at risk of developing COVID pneumonia. A trend in IL-6 levels was observed in patients on tocilizumab therapy.PMID:33988463 | DOI:10.2217/bmm-2020-0422

Source: Future Medicine: Biomarkers in Medicine - May 14, 2021 Category: Internal Medicine Authors: Eman Farid Kannan Sridharan Ola Am Alsegai Safa Al Khawaja Eman J Mansoor Noor A Teraifi Manaf Al Qahtani Jameela Al Salman Source Type: research